Fusarium verticillioides NAT1 (FDB2) N-malonyltransferase is structurally, functionally and phylogenetically distinct from its N-acetyltransferase (NAT) homologues
- PMID: 36178468
- DOI: 10.1111/febs.16642
Fusarium verticillioides NAT1 (FDB2) N-malonyltransferase is structurally, functionally and phylogenetically distinct from its N-acetyltransferase (NAT) homologues
Abstract
Fusarium endophytes damage cereal crops and contaminate produce with mycotoxins. Those fungi overcome the main chemical defence of host via detoxification by a malonyl-CoA-dependent enzyme homologous to xenobiotic metabolizing arylamine N-acetyltransferase (NAT). In Fusarium verticillioides (teleomorph Gibberella moniliformis, GIBMO), this N-malonyltransferase activity is attributed to (GIBMO)NAT1, and the fungus has two additional isoenzymes, (GIBMO)NAT3 (N-acetyltransferase) and (GIBMO)NAT2 (unknown function). We present the crystallographic structure of (GIBMO)NAT1, also modelling other fungal NAT homologues. Monomeric (GIBMO)NAT1 is distinctive, with access to the catalytic core through two "tunnel-like" entries separated by a "bridge-like" helix. In the quaternary arrangement, (GIBMO)NAT1 monomers interact in pairs along an extensive interface whereby one entry of each monomer is covered by the N-terminus of the other monomer. Although monomeric (GIBMO)NAT1 apparently accommodates acetyl-CoA better than malonyl-CoA, dimerization changes the active site to allow malonyl-CoA to reach the catalytic triad (Cys110, His158 and Asp173) via the single uncovered entry, and anchor its terminal carboxyl-group via hydrogen bonds to Arg109, Asn157 and Thr261. Lacking a terminal carboxyl-group, acetyl-CoA cannot form such stabilizing interactions, while longer acyl-CoAs enter the active site but cannot reach catalytic Cys. Other NAT isoenzymes lack such structural features, with (GIBMO)NAT3 resembling bacterial NATs and (GIBMO)NAT2 adopting a structure intermediate between (GIBMO)NAT1 and (GIBMO)NAT3. Biochemical assays confirmed differential donor substrate preference of (GIBMO)NAT isoenzymes, with phylogenetic analysis demonstrating evolutionary separation. Given the role of (GIBMO)NAT1 in enhancing Fusarium pathogenicity, unravelling the structure and function of this enzyme may benefit research into more targeted strategies for pathogen control.
Keywords: Fusarium; FDB2; NAT; acetyltransferase; malonyltransferase.
© 2022 Federation of European Biochemical Societies.
Similar articles
-
Polymorphism p.Val231Ile alters substrate selectivity of drug-metabolizing arylamine N-acetyltransferase 2 (NAT2) isoenzyme of rhesus macaque and human.Gene. 2014 Feb 15;536(1):65-73. doi: 10.1016/j.gene.2013.11.085. Epub 2013 Dec 11. Gene. 2014. PMID: 24333853
-
The actinobacterium Tsukamurella paurometabola has a functionally divergent arylamine N-acetyltransferase (NAT) homolog.World J Microbiol Biotechnol. 2019 Oct 31;35(11):174. doi: 10.1007/s11274-019-2755-1. World J Microbiol Biotechnol. 2019. PMID: 31673919
-
Differences between murine arylamine N-acetyltransferase type 1 and human arylamine N-acetyltransferase type 2 defined by substrate specificity and inhibitor binding.BMC Pharmacol Toxicol. 2014 Nov 29;15:68. doi: 10.1186/2050-6511-15-68. BMC Pharmacol Toxicol. 2014. PMID: 25432241 Free PMC article.
-
Arylamine N-acetyltransferases: structural and functional implications of polymorphisms.Toxicology. 2008 Dec 30;254(3):170-83. doi: 10.1016/j.tox.2008.08.022. Epub 2008 Sep 12. Toxicology. 2008. PMID: 18852012 Review.
-
Arylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discovery.Br J Pharmacol. 2014 Jun;171(11):2705-25. doi: 10.1111/bph.12598. Br J Pharmacol. 2014. PMID: 24467436 Free PMC article. Review.
Cited by
-
Insights into the genomic and functional divergence of NAT gene family to serve microbial secondary metabolism.Sci Rep. 2024 Jun 28;14(1):14905. doi: 10.1038/s41598-024-65342-4. Sci Rep. 2024. PMID: 38942826 Free PMC article.
References
-
- Boukouvala S, Fakis G. Arylamine N-acetyltransferases: what we learn from genes and genomes. Drug Metab Rev. 2005;37:511-64.
-
- Glenn AE, Karagianni EP, Ulndreaj A, Boukouvala S. Comparative genomic and phylogenetic investigation of the xenobiotic metabolizing arylamine N-acetyltransferase enzyme family. FEBS Lett. 2010;584:3158-64.
-
- Vagena E, Fakis G, Boukouvala S. Arylamine N-acetyltransferases in prokaryotic and eukaryotic genomes: a survey of public databases. Curr Drug Metab. 2008;9:628-60.
-
- Floss HG, Yu TW. Lessons from the rifamycin biosynthetic gene cluster. Curr Opin Chem Biol. 1999;3:592-7.
-
- Bhakta S, Besra GS, Upton AM, Parish T, Sholto-Douglas-Vernon C, Gibson KJC, et al. Arylamine N-acetyltransferase is required for synthesis of mycolic acids and complex lipids in Mycobacterium bovis BCG and represents a novel drug target. J Exp Med. 2004;199:1191-9.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources